A retrospective cohort study examined whether concurrent menopause hormone therapy modifies weight loss and cardiometabolic outcomes among postmenopausal women with overweight or obesity treated with...
A longitudinal analysis from the Western Australian Raine Study evaluated whether polycystic ovary syndrome coexisting with metabolic dysfunction–associated steatotic liver disease during adolescence is...
In a 12-week, multicenter, randomized, double-blind, placebo-controlled phase 2b trial, the selective hURAT1 inhibitor epaminurad produced rapid, dose-dependent reductions in serum urate in adults with...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
In this COVID-19 roundup, coverage includes the addition of an Omicron variant component to future vaccine boosters, the relationship between a COVID-19 infection and damage to heart muscle, and how...
Several cardiology society guidelines recommend that infected cardiac implantable electronic devices and its leads be completely removed from all patients. Researchers examined adherence to these...
The American Heart Association has released a new scientific statement on the relationship between exercise, heart health, and life events or transitions.
